NCT06316011

Brief Summary

This prospective cohort study is aimed at identification and risk stratification of patients who have symptoms of acute chest pain suspected with acute coronary syndrome (ACS) using Magnetocardiography (MCG).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,620

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 18, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

March 20, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 3, 2024

Status Verified

February 1, 2024

Enrollment Period

7 months

First QC Date

March 11, 2024

Last Update Submit

August 29, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Efficacy of MCG for the detection and risk stratification in high-risk patients with chest pain

    Establishing an algorithm model of MCG in identifying high-risk cardiogenic chest pain, the efficacy of the model was assessed by sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and AUC, etc.

    from the date of enrollment until the date of discharge, up to 30 days

  • Efficacy of MCG for the detection and risk stratification in low-risk patients with chest pain

    Establishing an algorithm model of MCG in identifying low-risk cardiogenic chest pain, the efficacy of the model was assessed by sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and AUC, etc.

    from the date of enrollment until the date of discharge, up to 30 days

Study Arms (2)

Training and testing cohort

Device: Magnetocardiography

External validation cohort

Device: Magnetocardiography

Interventions

Magnetocardiography

External validation cohortTraining and testing cohort

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patient who suffers from cardiogenic chest pain suspected with acute coronary syndrome (ACS).

You may qualify if:

  • Those with suspected ACS who presented with symptoms of acute chest pain.
  • Signed informed consent.

You may not qualify if:

  • Those with known structural heart disease such as cardiomyopathy and valvular disease;
  • Those with atrial fibrillation, supraventricular tachycardia, atrioventricular block and other arrhythmias that have not returned to normal;
  • Those who have chest pain with known pulmonary embolism or aortic coarctation;
  • Those who are thought to be incapable of completing the MCG examination by an attending physician (or physician with higher qualifications) due to unstable clinical conditions, metal implants, etc;
  • Those who are unable to perform magnetocardiography examinations due to claustrophobia, etc., or those who fail to receive magnetocardiography examination;
  • Those with malignant tumors;
  • Pregnant or lactating women.
  • Those with acute or critical illnesses of other systems, such as acute or severe respiratory illnesses, marked abnormalities in liver function or kidney function.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Qilu Hospital of Shandong University

Jinan, Shandong, 250012, China

RECRUITING

MeSH Terms

Conditions

Acute Coronary Syndrome

Interventions

Magnetocardiography

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisMagnetometryInvestigative Techniques

Study Officials

  • Yuguo Chen, Professor

    Qliu Hospital of Shandong University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jiaojiao Pang, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2024

First Posted

March 18, 2024

Study Start

March 20, 2024

Primary Completion

October 30, 2024

Study Completion

December 31, 2024

Last Updated

September 3, 2024

Record last verified: 2024-02

Locations